The Jill and Alan Miller Associate Professorship of Breast Cancer Excellence
Established in 2013, the Professorship was created by Jill and Alan B. Miller to celebrate Jill’s 20th anniversary as a breast cancer survivor.
At Penn Medicine, Jill Miller has been an advocate for breast cancer research and patient care, and the chair supports a faculty member of the Abramson Cancer Center in the field of breast cancer medical oncology. The Millers have also established the Alan B. Miller Professorship at Wharton, where Mr. Miller earned his MBA. He is currently Chairman and CEO of Universal Health Services, Inc., which he founded in 1978 and led to become one of the largest and most respected hospital management companies in the nation. Mr. Miller also founded and serves as Chairman of the Board, CEO, and President of Universal Health Realty Income Trust. He has been a member of Wharton’s Graduate Executive Board and Board of Overseers.
The Millers generously support and serve on the boards of many medical, higher education, and arts organizations.
Current Chairholder
Amy Clark, MD, MSCE
Dr. Amy Clark is an Associate Professor of Medicine in Hematology-Oncology at the Hospital of the University of Pennsylvania. Dr. Clark received her Bachelor of Science in Biology from Haverford College and subsequently conducted research at the National Cancer Institute (NCI), studying mechanisms of chemotherapy resistance in lung and breast cancers. She went on to receive her MD from the Milton S. Hershey Penn State College of Medicine and completed her residency in Internal Medicine at Boston University/Boston Medical Center, followed by a fellowship in Hematology/Oncology at the Hospital of the University of Pennsylvania. During her fellowship, she also earned a Master of Science in Clinical Epidemiology, with a concentration in Clinical Trials. Her area of focus is in breast cancer clinical trials, drug development, imaging biomarkers of response and resistance in hormone receptor positive breast cancer.
Dr. Clark is the Medical Director for the Clinical Research Unit at the Abramson Cancer Center, Physician Lead of the Breast Cancer Clinical Research Unit and serves as the Vice Chair for the Clinical Trials Scientific Monitoring Committee. She is a sub-Investigator, site Principal investigator and Principal Investigator on numerous trials including her investigator-initiated clinical trial, Abby, which is attempting to treat early-stage breast cancer patients found to have disseminated tumor cells. Dr. Clark also serves on the Metastatic Breast Cancer Scientific Committee for ASCO during the 2024-2026 term and is the Track Leader for 2026. She holds memberships in several organizations such as ASCO, ECOG and TBCRC.
Previous Chairholder
- Angela M. DeMichele, MD, MSCE 2013-2023